Abstract
Angiogenesis, the process of formation of new blood vessels, involves a complex interplay of various growth signals and cellular milieu. It plays an important role in many physiological and pathological processes. The study of angiogenesis has gained momentum from two different perspectives. On the one hand, angiogenesis is essential for physiologic processes such as menstrual bleeding, wound healing, and embryonic development; on the other hand, histopathologic studies suggest that angiogenesis has an important role in the growth of the atherosclerotic plaque and several tumors. From a clinical perspective, drugs that inhibit angiogenesis seem to increase the incidence of thromboembolic events. Recent data suggests that endothelial-derived growth factor (VEGF) constitutes only a small proportion of total body VEGF and does not contribute significantly to the overall angiogenic response. However, such autocrine VEGF signaling is required for endothelial cell survival and maintenance of vascular homeostasis. In parallel, the discovery of VEGF has guided us to therapeutic angiogenesis as a possible treatment for ischemic heart and peripheral disease. Results of numerous preclinical studies have provided evidence that angiogenic growth factors can promote collateral channel development which can reduce ischemia. Nonetheless, clinical trials on therapeutic angiogenesis have not been very impressive as expected. Bench and bedside research continues to bring insight into the mechanisms of tissue ischemia and tumor growth. Further understanding of different facets of angiogenesis may help in the development of novel and specific therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
Schaper W, Scholz D (2003) Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 23:1143–1151
Takahashi H, Shibuya M (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci 109:227–241
Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183
Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395
Sluimer JC, Daemen MJ (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 218:7–29
Ago T, Kuroda J, Kamouchi M et al (2011) Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-. Circ J 75:1791–1800
Jiang J, Yan M, Mehta JL, Hu C (2011) Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1. Cardiovasc Drugs Ther 25:461–468
Li D, Mehta JL (2000) Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20:1116–1122
Dandapat A, Hu C, Sun L, Mehta JL (2007) Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol 27:2435–2442
Kanata S, Akagi M, Nishimura S et al (2006) Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem Biophys Res Commun 348:1003–1010
Hu C, Dandapat A, Mehta JL (2007) Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway. Hypertension 50:952–957
Khaidakov M, Szwedo J, Mitra S et al (2010) Antiangiogenic and antimitotic effects of aspirin in hypoxia-reoxygenation modulation of the LOX-1-NADPH oxidase axis as a potential mechanism. J Cardiovasc Pharmacol 56:635–641
Koester W (1876) Endareritis and arteritis. Berl Klin Wochenschr 13:454–455
Winternitz MC, Thomas RM, LeCompte PM (1938) The biology of arteriosclerosis. C.C. Thomas, Springfield
Wilens SL, Plair CM (1965) Blood cholesterol, nutrition, atherosclerosis. A necropsy study. Arch Intern Med 116:373–380
Moreno PR, Purushothaman KR, Fuster V et al (2004) Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110:2032–2038
Kolodgie FD, Virmani R, Burke AP et al (2004) Pathologic assessment of the vulnerable human coronary plaque. Heart 90:1385–1391
Barger AC, Beeuwkes R III (1990) Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol 66:41–43
Moulton KS, Heller E, Konerding MA et al (1999) Angiogenesis inhibitors endostatin or TNP-Â470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:1726–1732
Moulton KS, Vakili K, Zurakowski D et al (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 100:4736–4741
Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD (2001) Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7:425–429
Khurana R, Zhuang Z, Bhardwaj S et al (2004) Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110:2436–2443
Zhao Q, Egashira K, Hiasa K et al (2004) Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 24:2284–2289
Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med 310:175–177
Mofidi R, Crotty TB, McCarthy P et al (2001) Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88:945–950
Hiyama T, Tanaka T, Endo S et al (2010) Angiogenesis in atherosclerotic plaque obtained from carotid endarterectomy: association between symptomatology and plaque morphology. Neurol Med Chir 50:1056–1061
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487
Kakehashi A, Inoda S, Mameuda C, Kuroki M et al (2008) Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy. Diabetes Res Clin Pract 79:438–445
Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300:2277–2285
Ranpura V, Hapani S, Chuang J, Wu S (2010) Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-Âanalysis of randomized controlled trials. Acta Oncol 49:287–297
Daher IN, Yeh ET (2008) Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 5:797–805
Menon SP, Rajkumar SV, Lacy M, Falco P, Palumbo A (2008) Thromboembolic events with lenalidomide-based therapy for multiple myeloma. Cancer 112:1522–1528
Sugimoto H, Hamano Y, Charytan D et al (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278:12605–12608
Lee S, Chen TT, Barber CL et al (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691–703
Kamba T, Tam BY, Hashizume H et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560–H576
Izumiya Y, Shiojima I, Sato K et al (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47:887–993
Van Royen N, Piek JJ, Schaper W et al (2001) Arteriogenesis: mechanisms and modulation of collateral artery development. J Nucl Cardiol 8:687–693
Chen CH, Walterscheid JP (2006) Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis. Circ Res 99:787–789
Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F (2002) Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res 11:81–90
Owman C, Hardebo JE (1988) Functional heterogeneity of cerebrovascular endothelium. Brain Behav Evol 32:65–75
Auerbach R (1992) Endothelial cell heterogeneity: its role as a determinant of selective metastasis. In: Simionescu N, Simionescu M (eds) Endothelial cell dysfunctions. Plenum Press, New York, pp 427–437
Belloni PN, Carney DH, Nicolson GL (1992) Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res 43:20–45
Chi JT, Chang HY, Haraldsen G, Jahnsen FL et al (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 100:10623–10628
Deng D, Tsalenko A, Vailaya A et al (2006) Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli. Circ Res 98:200–208
Page C, Rose M, Yacoub M, Pigott R (1991) Antigenic heterogeneity of vascular endothelium. Am J Pathol 141:677–683
Aird WC, Edelberg JM, Weiler-Guettler H et al (1997) Vascular bed-specific expression of an endothelial cell is programmed by the tissue microenvironment. J Cell Biol 138:1117–1124
Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E et al (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80:99–115
Simpson E, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19–27
Griep AE, Krawcek J, Lee D et al (1998) Multiple genetic loci modify risk for retinoblastoma in transgenic mice. Invest Ophthalmol Vis Sci 39:2723–2732
Thurston G, Murphy T, Baluk P, Lindsey JR, MacDonald DM (1998) Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 153:1099–1112
Rohan RM, Fernandez A, Udagawa T, Yuan J, D’Amato RJ (2000) Genetic heterogeneity of angiogenesis in mice. FASEB J 14:871–876
Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125:e2–e220
Ware JA, Simons M (1997) Angiogenesis in ischemic heart disease. Nat Med 3:158–164
Zachary I, Morgan RD (2011) Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 97:181–189
Henry TD, Annex BH, McKendall GR et al (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107:1359–1365
Simons M, Annex BH, Laham RJ et al (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788–793
Hedman M, Hartikainen J, Syvänne M et al (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107:2677–2683
Kastrup J, Jørgensen E, Rück A et al (2005) Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 45:982–988
Conflict of Interest
None
Disclosures  None
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pant, S., Deshmukh, A., Mehta, J.L. (2013). Angiogenesis in Atherosclerosis: An Overview. In: Mehta, J., Dhalla, N. (eds) Biochemical Basis and Therapeutic Implications of Angiogenesis. Advances in Biochemistry in Health and Disease, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5857-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5857-9_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5856-2
Online ISBN: 978-1-4614-5857-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)